Clinical Trials Browser

Phase 2 × Carcinoma, Merkel Cell × lenvatinib × Clear all

NCT04869137 2025-10-31

Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma

Phase 2 Active not recruiting

Skin Neoplasms, Carcinoma, Merkel Cell